Randomized Double-Blind Phase II Trial of Baby Exemestane Versus Baby Tamoxifen in Post-Menopausal Women at High Risk for Breast Cancer

Clinical trial NCT07499999 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07499999
Sponsor: Dana-Farber Cancer Institute
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Cancer Ductal Carcinoma Estrogen-receptor-positive Breast Cancer Atypical Lobular Hyperplasia BRCA2 Mutation CHEK2 Gene Mutation Ataxia Telangiectasia Mutated Gene Mutation

Start date: 2026-09-09
Primary completion: 2027-08-31
Enrollment: 140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.